Package 76420-923-01

{"route": ["ORAL"], "spl_id": "2ef18e19-2e59-5756-e063-6394a90a1a03", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["d1d0872c-5b11-4e13-a401-b122348e0fa7"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (76420-923-01)", "package_ndc": "76420-923-01", "marketing_start_date": "20250225"}, {"sample": false, "description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (76420-923-05)", "package_ndc": "76420-923-05", "marketing_start_date": "20250225"}, {"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (76420-923-30)", "package_ndc": "76420-923-30", "marketing_start_date": "20250225"}, {"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (76420-923-60)", "package_ndc": "76420-923-60", "marketing_start_date": "20250225"}, {"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (76420-923-90)", "package_ndc": "76420-923-90", "marketing_start_date": "20250225"}], "brand_name": "Bupropion Hydrochloride XL", "product_id": "76420-923_2ef18e19-2e59-5756-e063-6394a90a1a03", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "76420-923", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "XL", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA077715", "marketing_category": "ANDA", "marketing_start_date": "20081126", "listing_expiration_date": "20261231"}